Skip to content

It is study to see how much clinical effect of indigenous compound to relieving symptoms of premenstrual syndrome.

Randomized controlled clinical trial of indigenous compound in the management of pittavritta vyana vayu with special reference to premenstrual syndrome. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099807
Enrollment
70
Registered
2025-12-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Mahesh Uddhav Raut
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having regular menstrual cycle. 2) Patient age group 18 to 40 years. 3) Diagnosed patient of pittavritta vyana vayu with special reference to premenstrual syndrome.

Exclusion criteria

Exclusion criteria: 1) Women who on oral contraceptive and hormone replacement therapy. 2) Women with K/C/O severe systemic illnesses. 3) K/C/O any other psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
To study the clinical effect of Indigenous Compound in the management of pittavritta vyana vayu with special reference to premenstrual syndrome.Timepoint: 2 months

Secondary

MeasureTime frame
To study pittavritta vyana vayu with special reference to premenstrual syndrome. To study premenstrual syndrome in details. To study indigenous Compound in details.Timepoint: At 3rd Month

Countries

India

Contacts

Public ContactDr Hemalata Chandrashekhar Kongi

LRP Ayurvedic Medical College and Hospital PG Institute and Research Centre Urun Islampur

drkongihema@gmail.com9225347295

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026